4.7 Article

BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID-19 in New York

期刊

OBESITY
卷 29, 期 2, 页码 279-284

出版社

WILEY
DOI: 10.1002/oby.23076

关键词

-

资金

  1. National Institute on Aging of the National Institutes of Health [R24AG064191]
  2. National Library of Medicine of the National Institutes of Health [R01LM012836]

向作者/读者索取更多资源

This study found that patients with COVID-19 who were overweight or obese had an increased risk of requiring invasive mechanical ventilation, while underweight and obese patients had an increased risk of death. Pulmonary complications seem to be significant contributors to poor outcomes in COVID-19 infection.
Objective This study examined the association between BMI and clinical outcomes among patients with coronavirus disease 2019 (COVID-19) infection. Methods A total of 10,861 patients with COVID-19 infection who were admitted to the Northwell Health system hospitals between March 1, 2020, and April 27, 2020, were included in this study. BMI was classified as underweight, normal weight, overweight, and obesity classes I, II, and III. Primary outcomes were invasive mechanical ventilation (IMV) and death. Results A total of 243 (2.2%) patients were underweight, 2,507 (23.1%) were normal weight, 4,021 (37.0%) had overweight, 2,345 (21.6%) had obesity class I, 990 (9.1%) had obesity class II, and 755 (7.0%) had obesity class III. Patients who had overweight (odds ratio [OR] = 1.27 [95% CI: 1.11-1.46]), obesity class I (OR = 1.48 [95% CI: 1.27-1.72]), obesity class II (OR = 1.89 [95% CI: 1.56-2.28]), and obesity class III (OR = 2.31 [95% CI: 1.88-2.85]) had an increased risk of requiring IMV. Underweight and obesity classes II and III were statistically associated with death (OR = 1.44 [95% CI: 1.08-1.92]; OR = 1.25 [95% CI: 1.03-1.52]; OR = 1.61 [95% CI: 1.30-2.00], respectively). Among patients who were on IMV, BMI was not associated with inpatient deaths. Conclusions Patients who are underweight or who have obesity are at risk for mechanical ventilation and death, suggesting that pulmonary complications (indicated by IMV) are a significant contributor for poor outcomes in COVID-19 infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据